These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 25155798)

  • 1. Calibration of risk prediction models: impact on decision-analytic performance.
    Van Calster B; Vickers AJ
    Med Decis Making; 2015 Feb; 35(2):162-9. PubMed ID: 25155798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the Value of Individualized Information: The Impact of Poor Calibration or Discrimination in Outcome Prediction Models.
    Olchanski N; Cohen JT; Neumann PJ; Wong JB; Kent DM
    Med Decis Making; 2017 Oct; 37(7):790-801. PubMed ID: 28399375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decision curve analysis confirms higher clinical utility of multi-domain versus single-domain prediction models in patients with open abdomen treatment for peritonitis.
    Huber M; Schober P; Petersen S; Luedi MM
    BMC Med Inform Decis Mak; 2023 Apr; 23(1):63. PubMed ID: 37024840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of markers and risk prediction models: overview of relationships between NRI and decision-analytic measures.
    Van Calster B; Vickers AJ; Pencina MJ; Baker SG; Timmerman D; Steyerberg EW
    Med Decis Making; 2013 May; 33(4):490-501. PubMed ID: 23313931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and specificity can change in opposite directions when new predictive markers are added to risk models.
    Van Calster B; Steyerberg EW; D'Agostino RB; Pencina MJ
    Med Decis Making; 2014 May; 34(4):513-22. PubMed ID: 24378915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision curve analysis: a novel method for evaluating prediction models.
    Vickers AJ; Elkin EB
    Med Decis Making; 2006; 26(6):565-74. PubMed ID: 17099194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Traditional statistical methods for evaluating prediction models are uninformative as to clinical value: towards a decision analytic framework.
    Vickers AJ; Cronin AM
    Semin Oncol; 2010 Feb; 37(1):31-8. PubMed ID: 20172362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using the weighted area under the net benefit curve for decision curve analysis.
    Talluri R; Shete S
    BMC Med Inform Decis Mak; 2016 Jul; 16():94. PubMed ID: 27431531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives.
    Steyerberg EW; Vedder MM; Leening MJ; Postmus D; D'Agostino RB; Van Calster B; Pencina MJ
    Biom J; 2015 Jul; 57(4):556-70. PubMed ID: 25042996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ROC curves for clinical prediction models part 1. ROC plots showed no added value above the AUC when evaluating the performance of clinical prediction models.
    Verbakel JY; Steyerberg EW; Uno H; De Cock B; Wynants L; Collins GS; Van Calster B
    J Clin Epidemiol; 2020 Oct; 126():207-216. PubMed ID: 32712176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simpson's paradox in the integrated discrimination improvement.
    Chipman J; Braun D
    Stat Med; 2017 Dec; 36(28):4468-4481. PubMed ID: 29160558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating a new marker for risk prediction: decision analysis to the rescue.
    Baker SG; Kramer BS
    Discov Med; 2012 Sep; 14(76):181-8. PubMed ID: 23021372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recalibration Methods for Improved Clinical Utility of Risk Scores.
    Mishra A; McClelland RL; Inoue LYT; Kerr KF
    Med Decis Making; 2022 May; 42(4):500-512. PubMed ID: 34605718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating a new marker for risk prediction using the test tradeoff: an update.
    Baker SG; Van Calster B; Steyerberg EW
    Int J Biostat; 2012 Mar; 8(1):. PubMed ID: 22499728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decision curve analysis to evaluate the clinical benefit of prediction models.
    Vickers AJ; Holland F
    Spine J; 2021 Oct; 21(10):1643-1648. PubMed ID: 33676020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Patient-Reported Outcome Mortality Prediction Tool (PROMPT).
    Duarte CW; Black AW; Murray K; Haskins AE; Lucas L; Hallen S; Han PK
    J Pain Symptom Manage; 2015 Aug; 50(2):241-7.e6. PubMed ID: 25891663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A calibration hierarchy for risk models was defined: from utopia to empirical data.
    Van Calster B; Nieboer D; Vergouwe Y; De Cock B; Pencina MJ; Steyerberg EW
    J Clin Epidemiol; 2016 Jun; 74():167-76. PubMed ID: 26772608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of a long-term cardiovascular disease risk prediction equation for low-incidence populations: the CAMUNI-MATISS Cohorts Collaboration study.
    Veronesi G; Gianfagna F; Giampaoli S; Chambless LE; Grassi G; Cesana G; Ferrario MM
    Eur J Prev Cardiol; 2015 Dec; 22(12):1618-25. PubMed ID: 25501263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple Decision-Analytic Functions of the AUC for Ruling Out a Risk Prediction Model and an Added Predictor.
    Baker SG
    Med Decis Making; 2018 Feb; 38(2):225-234. PubMed ID: 29025299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Net reclassification index at event rate: properties and relationships.
    Pencina MJ; Steyerberg EW; D'Agostino RB
    Stat Med; 2017 Dec; 36(28):4455-4467. PubMed ID: 27426413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.